Literature DB >> 35404441

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.

Ajit J Nirmal1,2,3, Zoltan Maliga1,2, Tuulia Vallius1,2, Sandro Santagata1,2,4, Peter K Sorger1,2,5, Brian Quattrochi4, Alyce A Chen1,2, Connor A Jacobson1,2, Roxanne J Pelletier1,2, Clarence Yapp1,2, Raquel Arias-Camison1,2,4, Yu-An Chen1,2, Christine G Lian4, George F Murphy4.   

Abstract

Cutaneous melanoma is a highly immunogenic malignancy that is surgically curable at early stages but life-threatening when metastatic. Here we integrate high-plex imaging, 3D high-resolution microscopy, and spatially resolved microregion transcriptomics to study immune evasion and immunoediting in primary melanoma. We find that recurrent cellular neighborhoods involving tumor, immune, and stromal cells change significantly along a progression axis involving precursor states, melanoma in situ, and invasive tumor. Hallmarks of immunosuppression are already detectable in precursor regions. When tumors become locally invasive, a consolidated and spatially restricted suppressive environment forms along the tumor-stromal boundary. This environment is established by cytokine gradients that promote expression of MHC-II and IDO1, and by PD1-PDL1-mediated cell contacts involving macrophages, dendritic cells, and T cells. A few millimeters away, cytotoxic T cells synapse with melanoma cells in fields of tumor regression. Thus, invasion and immunoediting can coexist within a few millimeters of each other in a single specimen. SIGNIFICANCE: The reorganization of the tumor ecosystem in primary melanoma is an excellent setting in which to study immunoediting and immune evasion. Guided by classic histopathology, spatial profiling of proteins and mRNA reveals recurrent morphologic and molecular features of tumor evolution that involve localized paracrine cytokine signaling and direct cell-cell contact. This article is highlighted in the In This Issue feature, p. 1397. ©2022 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35404441      PMCID: PMC9167783          DOI: 10.1158/2159-8290.CD-21-1357

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  103 in total

1.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

2.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

Review 3.  Narrative online guides for the interpretation of digital-pathology images and tissue-atlas data.

Authors:  Rumana Rashid; Yu-An Chen; John Hoffer; Jeremy L Muhlich; Jia-Ren Lin; Robert Krueger; Hanspeter Pfister; Richard Mitchell; Sandro Santagata; Peter K Sorger
Journal:  Nat Biomed Eng       Date:  2021-11-08       Impact factor: 29.234

4.  BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.

Authors:  Rizwan Haq; Satoru Yokoyama; Elena B Hawryluk; Göran B Jönsson; Dennie Tompers Frederick; Kevin McHenry; Dale Porter; Thanh-Nga Tran; Kevin T Love; Robert Langer; Daniel G Anderson; Levi A Garraway; Lyn McDivitt Duncan; Donald L Morton; Dave S B Hoon; Jennifer A Wargo; Jun S Song; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-27       Impact factor: 11.205

5.  Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.

Authors:  Rikke B Holmgaard; Dmitriy Zamarin; Yanyun Li; Billel Gasmi; David H Munn; James P Allison; Taha Merghoub; Jedd D Wolchok
Journal:  Cell Rep       Date:  2015-09-24       Impact factor: 9.423

6.  The single-cell pathology landscape of breast cancer.

Authors:  Hartland W Jackson; Jana R Fischer; Vito R T Zanotelli; H Raza Ali; Robert Mechera; Savas D Soysal; Holger Moch; Simone Muenst; Zsuzsanna Varga; Walter P Weber; Bernd Bodenmiller
Journal:  Nature       Date:  2020-01-20       Impact factor: 49.962

7.  The Genetic Evolution of Melanoma from Precursor Lesions.

Authors:  A Hunter Shain; Iwei Yeh; Ivanka Kovalyshyn; Aravindhan Sriharan; Eric Talevich; Alexander Gagnon; Reinhard Dummer; Jeffrey North; Laura Pincus; Beth Ruben; William Rickaby; Corrado D'Arrigo; Alistair Robson; Boris C Bastian
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

Review 8.  Ki-67: more than a proliferation marker.

Authors:  Xiaoming Sun; Paul D Kaufman
Journal:  Chromosoma       Date:  2018-01-10       Impact factor: 4.316

9.  Biomarker Discovery and Validation: Statistical Considerations.

Authors:  Fang-Shu Ou; Stefan Michiels; Yu Shyr; Alex A Adjei; Ann L Oberg
Journal:  J Thorac Oncol       Date:  2021-02-02       Impact factor: 15.609

10.  Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

Authors:  Christine Guo Lian; Yufei Xu; Craig Ceol; Feizhen Wu; Allison Larson; Karen Dresser; Wenqi Xu; Li Tan; Yeguang Hu; Qian Zhan; Chung-Wei Lee; Di Hu; Bill Q Lian; Sonja Kleffel; Yijun Yang; James Neiswender; Abraham J Khorasani; Rui Fang; Cecilia Lezcano; Lyn M Duncan; Richard A Scolyer; John F Thompson; Hojabr Kakavand; Yariv Houvras; Leonard I Zon; Martin C Mihm; Ursula B Kaiser; Tobias Schatton; Bruce A Woda; George F Murphy; Yujiang G Shi
Journal:  Cell       Date:  2012-09-14       Impact factor: 66.850

View more
  8 in total

1.  Light-Seq: light-directed in situ barcoding of biomolecules in fixed cells and tissues for spatially indexed sequencing.

Authors:  Jocelyn Y Kishi; Ninning Liu; Emma R West; Kuanwei Sheng; Jack J Jordanides; Matthew Serrata; Constance L Cepko; Sinem K Saka; Peng Yin
Journal:  Nat Methods       Date:  2022-10-10       Impact factor: 47.990

Review 2.  Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies.

Authors:  Simone Caligola; Francesco De Sanctis; Stefania Canè; Stefano Ugel
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

3.  In situ functional cell phenotyping reveals microdomain networks in colorectal cancer recurrence.

Authors:  Samantha A Furman; Andrew M Stern; Shikhar Uttam; D Lansing Taylor; Filippo Pullara; S Chakra Chennubhotla
Journal:  Cell Rep Methods       Date:  2021-09-15

4.  Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+ T Exhausted State to be Associated with Clinical Benefits in Melanoma.

Authors:  Jiali Zhu; Min Yan; Haoteng Yan; Liwen Xu; Zedong Jiang; Gaoming Liao; Yao Zhou; Wei Liu; Xin Liang; Xia Li; Yun Xiao; Yunpeng Zhang
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 5.  Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level.

Authors:  Francesca Maria Bosisio; Yannick Van Herck; Julie Messiaen; Maddalena Maria Bolognesi; Lukas Marcelis; Matthias Van Haele; Giorgio Cattoretti; Asier Antoranz; Frederik De Smet
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

6.  Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma.

Authors:  Shannon Coy; Shu Wang; Sylwia A Stopka; Jia-Ren Lin; Clarence Yapp; Cecily C Ritch; Lisa Salhi; Gregory J Baker; Rumana Rashid; Gerard Baquer; Michael Regan; Prasidda Khadka; Kristina A Cole; Jaeho Hwang; Patrick Y Wen; Pratiti Bandopadhayay; Mariarita Santi; Thomas De Raedt; Keith L Ligon; Nathalie Y R Agar; Peter K Sorger; Mehdi Touat; Sandro Santagata
Journal:  Nat Commun       Date:  2022-08-16       Impact factor: 17.694

7.  Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome.

Authors:  Grace H Attrill; Hansol Lee; Annie T Tasker; Nurudeen A Adegoke; Angela L Ferguson; Ines Pires da Silva; Robyn P M Saw; John F Thompson; Umaimainthan Palendira; Georgina V Long; Peter M Ferguson; Richard A Scolyer; James S Wilmott
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

Review 8.  An introduction to spatial transcriptomics for biomedical research.

Authors:  Cameron G Williams; Hyun Jae Lee; Takahiro Asatsuma; Roser Vento-Tormo; Ashraful Haque
Journal:  Genome Med       Date:  2022-06-27       Impact factor: 15.266

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.